About CPF
Company Profiles
Awards
Global Collaboration
Media Center
Subsidiary
Products & Services
API and intermediates
Dosage
Services
R&D
News
Company News
Industry News
Contact Us
中
About CPF
Products & Services
R&D
News
Contact Us
API and intermediates
Dosage
Services
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
No.
Product
Crystal form
Current batch size
USDMF
EUDMF
1
Lenalidomide
Form A
6-10kg
USDMF31804
EUDMF
2
Niraparib tosylate monohydrate
Form I
25-28Kg
USDMF
3
Obeticholic Acid
Amorphous
16.5-18.7kg
USDMF37355
4
Orforglipron
Amorphous
100~300g
5
Osimertinib Mesylate
Form B
10-50g
6
Oteseconazole
Anhydrous crystalline form
2-3Kg
7
Pitavastatin Calcium
8
Pomalidomide
Form A
5.2-10.8kg
DMF
9
Pregabalin
As Innovator
150kg/925kg
USDMF22223
EUDMF/CEP 2016-141
10
Pregabalin Capsules
50mg/75mg/100mg/150mg/200mg/225mg/300mg
Epilepsy/Neuralgia
11
Relugolix
Anhydrous Non-solvent Form
17-19kg
DMF
12
Remdesivir
DMF
13
Resmetirom
Form I and Form λ
40-50 kg
14
Rimegepant Sulfate
Form H1.5-1
8-12 kg
USDMF 38655
15
Rivaroxaban
Form Ⅰ
140-150kg
USDMF34436
EUDMF/CEP 2021-252
16
Rosuvastatin Calcium
Amorphous
205kg-225kg
USDMF20705 (RS) /34974 (RSF)
EUDMF /CEP 2015-240(RS) /CEP 2020-430(RSF)
17
Rosuvastatin Calcium Tablets
5mg/10mg/20mg/40mg
Hypercholesterolemia
18
Ruxolitinib Phosphate
As Innovator
14-17kg
USDMF
19
Sacubitril Hemicalcium
20
Sacubitril Sodium
Form B
78-80kg
USDMF35962
EUDMF
1
2
3
4
Leave Your Message
SEND OUT